Table 4 from A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid TumorsRémi Vernet,Eugenio Fernandez,Denis Migliorini, Virginie Ancrenaz,Emily Charrier,Marie-Claude Belkouch,Olivier Von Rohr,Muriel Urwyler,Claudio De Vito, Jessica Renaux,Jean Villard,Olivier Rubin,Julien Grogg,Nicolas Machcrossref（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
